In other studies of acute myeloid leukaemia patients, administration of GM-CSF led to recovery of neutrophil counts and was associated with a more rapid clearance of infection when compared with a historical control group that did not receive GM-CSF (356), including fungal infections (357). Here, CSF2 is linked to infection.